Neuroblastoma Clinical Trials in Chicago, Illinois
10 recruitingChicago, Illinois
Showing 1–10 of 10 trials
Recruiting
Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
NeuroblastomaGanglioneuroblastoma, Nodular
National Cancer Institute (NCI)478 enrolled177 locationsNCT06172296
Recruiting
Phase 2
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Giselle Sholler500 enrolled28 locationsNCT02559778
Recruiting
Phase 2
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium62 enrolled13 locationsNCT06450041
Recruiting
Neuroblastoma Biology Study
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium1,000 enrolled17 locationsNCT01587300
Recruiting
Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
NeuroblastomaGanglioneuroblastoma, NodularGanglioneuroblastoma
Children's Oncology Group750 enrolled162 locationsNCT03126916
Recruiting
Phase 1Phase 2
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more
Children's Oncology Group147 enrolled21 locationsNCT04851119
Recruiting
Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
Neuroblastoma
Y-mAbs Therapeutics122 enrolled26 locationsNCT03363373
Recruiting
Phase 2
Neuroblastoma Maintenance Therapy Trial
Neuroblastoma
Giselle Sholler441 enrolled49 locationsNCT02679144
Recruiting
Phase 1
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
SarcomaSCLCMalignant Melanoma+1 more
Y-mAbs Therapeutics60 enrolled8 locationsNCT05130255
Recruiting
Neurocognition in Congenital Central Hypoventilation Syndrome (CCHS)
Congenital Central Hypoventilation SyndromeCongenital Central HypoventilationCCHS+3 more
Debra Weese-Mayer1,000 enrolled4 locationsNCT03568669